These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31800319)

  • 41. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
    Backonja M; Glanzman RL
    Clin Ther; 2003 Jan; 25(1):81-104. PubMed ID: 12637113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Very-Low-Dose Methadone To Treat Refractory Neuropathic Pain in Children with Cancer.
    Madden K; Bruera E
    J Palliat Med; 2017 Nov; 20(11):1280-1283. PubMed ID: 28609177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are cannabinoids effective for orofacial pain states?
    Sessle BJ
    J Oral Facial Pain Headache; 2015; 29(1):5-6. PubMed ID: 25715439
    [No Abstract]   [Full Text] [Related]  

  • 44. Beneficial effect of gabapentin in two children with Noonan syndrome and early-onset neuropathic pain.
    Cortellazzo Wiel L; De Nardi L; Magnolato A; Sirchia F; Bruno I; Barbi E
    Am J Med Genet A; 2020 Aug; 182(8):1990-1992. PubMed ID: 32627323
    [No Abstract]   [Full Text] [Related]  

  • 45. Gabapentin adjunctive therapy in neuropathic pain states.
    Rosner H; Rubin L; Kestenbaum A
    Clin J Pain; 1996 Mar; 12(1):56-8. PubMed ID: 8722736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnosis and treatment of chronic pain by pain clinicians].
    Hashizume K
    Brain Nerve; 2012 Nov; 64(11):1315-22. PubMed ID: 23131743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.
    Gilron I; Bailey JM; Tu D; Holden RR; Jackson AC; Houlden RL
    Lancet; 2009 Oct; 374(9697):1252-61. PubMed ID: 19796802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain.
    Yelland MJ; Poulos CJ; Pillans PI; Bashford GM; Nikles CJ; Sturtevant JM; Vine N; Del Mar CB; Schluter PJ; Tan M; Chan J; Mackenzie F; Brown R
    Pain Med; 2009; 10(4):754-61. PubMed ID: 19453961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postherpetic neuralgia: role of gabapentin and other treatment modalities.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S51-6; discussion S73-4. PubMed ID: 10530683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms.
    Ahn SH; Park HW; Lee BS; Moon HW; Jang SH; Sakong J; Bae JH
    Spine (Phila Pa 1976); 2003 Feb; 28(4):341-6; discussion 346-7. PubMed ID: 12590206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of pain medication use in older individuals with cardiovascular disease.
    Kabbara WK; Dimassi H; Sheikh-Taha M
    Curr Med Res Opin; 2018 May; 34(5):931-934. PubMed ID: 29490511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of gabapentin for the treatment of postherpetic neuralgia.
    Singh D; Kennedy DH
    Clin Ther; 2003 Mar; 25(3):852-89. PubMed ID: 12852705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The gabapentinoid drugs and their abuse potential.
    Goins A; Patel K; Alles SRA
    Pharmacol Ther; 2021 Nov; 227():107926. PubMed ID: 34171338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comment on: Serpell et al., gabapentin in neuropathic pain syndromes: a randomised double-blind, placebo controlled trial (Pain 2002; 99: 557-66).
    McCleane GJ
    Pain; 2003 May; 103(1-2):227; author reply 228. PubMed ID: 12749981
    [No Abstract]   [Full Text] [Related]  

  • 55. Minimal incidence of chronic and neuropathic postthoracotomy pain after anteroaxillary thoracotomy with consequent systemic pain therapy.
    Kampe S; Lüttecke D; Wolter K; Cheufou DH; Stamatis G
    Eur J Anaesthesiol; 2014 Sep; 31(9):508-11. PubMed ID: 24145805
    [No Abstract]   [Full Text] [Related]  

  • 56. Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory pain.
    Aramini A; Bianchini G; Lillini S; Tomassetti M; Pacchiarotti N; Canestrari D; Cocchiaro P; Novelli R; Dragani MC; Palmerio F; Mattioli S; Bordignon S; d'Angelo M; Castelli V; d'Egidio F; Maione S; Luongo L; Boccella S; Cimini A; Brandolini L; Chierotti MR; Allegretti M
    Biomed Pharmacother; 2023 Jul; 163():114845. PubMed ID: 37167730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The challenge of neuropathic pain].
    Martínez-Salio A
    Med Clin (Barc); 2012 Jun; 139(1):16-7. PubMed ID: 22401728
    [No Abstract]   [Full Text] [Related]  

  • 58. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature.
    Mellegers MA; Furlan AD; Mailis A
    Clin J Pain; 2001 Dec; 17(4):284-95. PubMed ID: 11783808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence, regulation and 'rational' prescribing: the case of gabapentin for neuropathic pain.
    Ghinea N; Lipworth W; Kerridge I
    J Eval Clin Pract; 2015 Feb; 21(1):28-33. PubMed ID: 24986307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
    Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
    Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.